Product NDC: | 0517-4905 |
Proprietary Name: | Dexamethasone Sodium Phosphates |
Non Proprietary Name: | Dexamethasone Phosphate |
Active Ingredient(s): | 4 mg/mL & nbsp; Dexamethasone Phosphate |
Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-4905 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087440 |
Marketing Category: | ANDA |
Start Marketing Date: | 19900930 |
Package NDC: | 0517-4905-25 |
Package Description: | 25 VIAL, MULTI-DOSE in 1 TRAY (0517-4905-25) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0517-4905-25 |
Proprietary Name | Dexamethasone Sodium Phosphates |
Package Description | 25 VIAL, MULTI-DOSE in 1 TRAY (0517-4905-25) > 5 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0517-4905 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dexamethasone Phosphate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE |
Start Marketing Date | 19900930 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | DEXAMETHASONE PHOSPHATE |
Strength Number | 4 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |